InsiderClue
← All stocks

FATE THERAPEUTICS INC

FATE Net buying
CIK 0001434316 #3595 in the set updated 20 Sep 2026
Bought (120 mo)
$137.64M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$129.44M
$177.25K on a plan · $81.30M straight out of an exercise
Sold at will
$47.96M
197 of 363 sales
Net
+$8.20M
+$89.68M against sales at will

By person

23 insiders · 387 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Redmile Group, LLC entity
Director
$135.69M (9)
$2.34M (2)
+$133.35M
38,801,402
32.38%
$95.44M
+20.5%
Wolchko J Scott
President and CEO
—
$49.07M (80) scheduled
−$49.07M
371,248
0.3098%
$913.20K
+161.4%
TAHL CINDY
See Remarks
—
$28.74M (65) scheduled
−$28.74M
589,355
0.4919%
$1.45M
+1,001%
Nashat Amir
Director
—
$22.96M (84)
−$22.96M
11,034
0.0092%
$27.14K
−99.2%
Valamehr Bahram
President and CEO
—
$14.35M (55) scheduled
−$14.35M
591,815
0.4939%
$1.46M
+659.1%
Shoemaker Daniel D
Chief Scientific Officer
—
$6.63M (29)
−$6.63M
73,020
0.0609%
$179.61K
−29.7%
Dulac Edward J III
Chief Financial Officer
—
$2.88M (17) scheduled
−$2.88M
101,479
0.0847%
$249.62K
—
Chu Yu-Waye
Chief Medical Officer
—
$1.05M (16)
−$1.05M
140,676
0.1174%
$346.03K
+106.6%
RASTETTER WILLIAM H
Director
$1,000.00K (1)
—
+$1,000.00K
642,424
0.5362%
$1.58M
+218.5%
MENDLEIN JOHN
Director
$698.14K (2)
$1.14M (3) scheduled
−$438.15K
311,231
0.2597%
$765.57K
+110.1%
Coughlin Timothy
Director
$150.00K (1)
$32.82K (1)
+$117.17K
9,892
0.0083%
$24.33K
—
Plavsic Mark
Chief Technical Officer
—
$109.43K (2)
−$109.43K
123,705
0.1032%
$304.29K
—
Storgard Chris
Chief Medical Officer
$100.00K (1)
—
+$100.00K
46,683
0.0390%
$114.83K
+413.6%
Agarwal Shefali
Director
—
$36.81K (2)
−$36.81K
10,490
0.0088%
$25.80K
+1,200%
Jooss Karin
Director
—
$33.84K (1)
−$33.84K
9,848
0.0082%
$24.22K
—
Xu Yuan
Director
—
$24.33K (3) scheduled
−$24.33K
8,669
0.0072%
$21.32K
—
Powl Brian T.
Chief Commercial Officer
—
$18.77K (1)
−$18.77K
41,146
0.0343%
$101.21K
—
HERSHBERG ROBERT
Director
—
$15.29K (1)
−$15.29K
10,659
0.0089%
$26.22K
—
Bressi Jerome Charles
See Remarks
—
$9.27K (1)
−$9.27K
335,203
0.2798%
$824.53K
+21.4%
Adawi Kamal
Chief Financial Officer
—
—
—
100,000
0.0835%
$245.98K
—
ABBOT STEWART
Chief Development Officer
—
—
—
64,917
0.0542%
$159.68K
+48.0%
EPSTEIN ROBERT S
Director
—
—
—
36,331
0.0303%
$89.37K
—
Lee Michael Stewart
Director
—
—
—
11,331
0.0095%
$27.87K
—

Individual transactions

97
Insider
Date
Role
Action
Shares
Price
Amount
Valamehr Bahram
4 Aug 2026
President and CEO
Sell
43,947
$2.46
$108.10K
TAHL CINDY
4 Aug 2026
See Remarks
Sell
38,800
$2.46
$95.41K
Valamehr Bahram
20 May 2026
President and CEO
Sell
28,946
$1.88
$54.48K
TAHL CINDY
20 May 2026
See Remarks
Sell
25,590
$1.88
$48.08K
Valamehr Bahram
9 Jan 2026
President and CEO
Sell
5,190
$1.07
$5.56K
TAHL CINDY
9 Jan 2026
See Remarks
Sell
10,589
$1.06
$11.28K
Valamehr Bahram
4 Aug 2025
President and CEO
Sell
14,466
$1.06
$15.40K
TAHL CINDY
4 Aug 2025
See Remarks
Sell
9,037
$1.06
$9.57K
Valamehr Bahram
10 Jan 2025
President and CEO
Sell
8,705
$1.54
$13.41K
TAHL CINDY
10 Jan 2025
See Remarks
Sell
5,654
$1.55
$8.76K
Bressi Jerome Charles
10 Jan 2025
See Remarks
Sell
5,980
$1.55
$9.27K
Redmile Group, LLC
20 Dec 2024
Director
Sell indirect
341,633
$1.68
$573.94K
Dulac Edward J III
9 Jan 2024
Chief Financial Officer
Sell
7,028
$4.37
$30.71K
Wolchko J Scott
9 Jan 2024
President and CEO
Sell
14,391
$4.37
$62.89K
Valamehr Bahram
9 Jan 2024
Chief R&D Officer
Sell
11,271
$4.38
$49.37K
TAHL CINDY
9 Jan 2024
General Counsel and Secretary
Sell
10,874
$4.37
$47.52K
Dulac Edward J III
18 Aug 2023
Chief Financial Officer
Sell
4,718
$2.80
$13.21K
Powl Brian T.
5 Jul 2023
Chief Commercial Officer
Sell
3,854
$4.87
$18.77K
Redmile Group, LLC
14 Apr 2023
Director
Sell indirect
302,339
$5.84
$1.77M
Chu Yu-Waye
10 Jan 2023
Chief Medical Officer
Sell
7,825
$5.24
$41.00K
Dulac Edward J III
10 Jan 2023
Chief Financial Officer
Sell
7,331
$5.24
$38.41K
Plavsic Mark
10 Jan 2023
Chief Technical Officer
Sell
3,418
$5.24
$17.91K
TAHL CINDY
10 Jan 2023
General Counsel and Secretary
Sell
11,553
$5.24
$60.54K
Valamehr Bahram
10 Jan 2023
Chief R&D Officer
Sell
10,917
$5.24
$57.21K
Wolchko J Scott
10 Jan 2023
President and CEO
Sell
45,907
$5.24
$240.55K
Dulac Edward J III
18 Aug 2022
Chief Financial Officer
Sell
432
$30.41
$13.14K
Dulac Edward J III
18 Aug 2022
Chief Financial Officer
Sell
4,703
$29.75
$139.91K
Plavsic Mark
5 Jul 2022
Chief Technical Officer
Sell
3,719
$24.61
$91.52K
Agarwal Shefali
7 Jun 2022
Director
Sell
841
$21.89
$18.41K
Agarwal Shefali
3 Jun 2022
Director
Sell
807
$22.80
$18.40K
Coughlin Timothy
3 Jun 2022
Director
Sell
1,439
$22.81
$32.82K
HERSHBERG ROBERT
3 Jun 2022
Director
Sell
672
$22.75
$15.29K
Jooss Karin
3 Jun 2022
Director
Sell
1,483
$22.82
$33.84K
MENDLEIN JOHN
3 Jun 2022
Director
Sell
1,364
$22.79
$31.09K
Chu Yu-Waye
19 Apr 2022
Chief Medical Officer
Sell
4,062
$35.37
$143.67K
Chu Yu-Waye
11 Jan 2022
Senior VP Clinical Development
Sell
418
$49.10
$20.52K
Chu Yu-Waye
11 Jan 2022
Senior VP Clinical Development
Sell
3,547
$48.44
$171.82K
Dulac Edward J III
11 Jan 2022
Chief Financial Officer
Sell
390
$49.16
$19.17K
Dulac Edward J III
11 Jan 2022
Chief Financial Officer
Sell
1,380
$48.25
$66.59K
Valamehr Bahram
11 Jan 2022
Chief R&D Officer
Sell
418
$49.12
$20.53K
Valamehr Bahram
11 Jan 2022
Chief R&D Officer
Sell
4,152
$48.44
$201.12K
TAHL CINDY
11 Jan 2022
General Counsel and Secretary
Sell
536
$49.15
$26.34K
TAHL CINDY
11 Jan 2022
General Counsel and Secretary
Sell
4,883
$48.46
$236.63K
Wolchko J Scott
11 Jan 2022
President and CEO
Sell
4,519
$49.07
$221.75K
Wolchko J Scott
11 Jan 2022
President and CEO
Sell
10,047
$48.50
$487.28K
Valamehr Bahram
10 Jan 2022
Chief R&D Officer
Sell
351
$47.17
$16.56K
Valamehr Bahram
10 Jan 2022
Chief R&D Officer
Sell
5,245
$46.33
$243.00K
TAHL CINDY
10 Jan 2022
General Counsel and Secretary
Sell
643
$47.15
$30.32K
TAHL CINDY
10 Jan 2022
General Counsel and Secretary
Sell
7,095
$46.37
$329.00K
Wolchko J Scott
10 Jan 2022
President and CEO
Sell
101
$47.72
$4.82K
Wolchko J Scott
10 Jan 2022
President and CEO
Sell
20,894
$47.17
$985.57K
Wolchko J Scott
10 Jan 2022
President and CEO
Sell
13,161
$46.36
$610.14K
Dulac Edward J III
19 Aug 2021
Chief Financial Officer
Sell
63
$90.00
$5.67K
Dulac Edward J III
19 Aug 2021
Chief Financial Officer
Sell
1,474
$88.65
$130.67K
Dulac Edward J III
19 Aug 2021
Chief Financial Officer
Sell
1,937
$87.90
$170.26K
Chu Yu-Waye
16 Apr 2021
Senior VP Clinical Development
Sell
1,500
$84.41
$126.62K
Chu Yu-Waye
16 Apr 2021
Senior VP Clinical Development
Sell
900
$82.91
$74.62K
Chu Yu-Waye
16 Apr 2021
Senior VP Clinical Development
Sell
875
$81.80
$71.58K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
800
$86.70
$69.36K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,900
$85.50
$247.96K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,728
$84.20
$229.70K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,480
$83.46
$206.99K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,993
$81.60
$244.22K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
5,174
$80.73
$417.72K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
4,627
$79.58
$368.24K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
3,298
$78.60
$259.24K
Shoemaker Daniel D
11 Jan 2021
Chief Scientific Officer
Sell
871
$109.65
$95.51K
Shoemaker Daniel D
11 Jan 2021
Chief Scientific Officer
Sell
1,050
$110.76
$116.30K
Shoemaker Daniel D
11 Jan 2021
Chief Scientific Officer
Sell
1,332
$111.62
$148.67K
TAHL CINDY
11 Jan 2021
General Counsel and Secretary
Sell
872
$109.65
$95.62K
TAHL CINDY
11 Jan 2021
General Counsel and Secretary
Sell
1,050
$110.76
$116.30K
TAHL CINDY
11 Jan 2021
General Counsel and Secretary
Sell
1,332
$111.62
$148.67K
Valamehr Bahram
11 Jan 2021
Chief Development Officer
Sell
871
$109.65
$95.51K
Valamehr Bahram
11 Jan 2021
Chief Development Officer
Sell
1,051
$110.76
$116.41K
Valamehr Bahram
11 Jan 2021
Chief Development Officer
Sell
1,332
$111.62
$148.67K
Wolchko J Scott
11 Jan 2021
President and CEO
Sell
2,300
$109.65
$252.20K
Wolchko J Scott
11 Jan 2021
President and CEO
Sell
2,772
$110.76
$307.02K
Wolchko J Scott
11 Jan 2021
President and CEO
Sell
3,515
$111.62
$392.33K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
151
$114.76
$17.33K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
872
$115.80
$100.98K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
2,451
$117.15
$287.14K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
2,755
$117.60
$323.99K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
151
$114.76
$17.33K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
872
$115.80
$100.98K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
2,451
$117.15
$287.14K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
2,755
$117.60
$323.99K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
151
$114.76
$17.33K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
872
$115.80
$100.98K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
2,451
$117.15
$287.14K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
2,756
$117.60
$324.10K
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
1,469
$114.76
$168.58K
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
8,515
$115.80
$986.03K
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
23,932
$117.15
$2.80M
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
26,904
$117.60
$3.16M
Shoemaker Daniel D
16 Nov 2020
Chief Scientific Officer
Sell
14,781
$52.40
$774.51K
Shoemaker Daniel D
16 Nov 2020
Chief Scientific Officer
Sell
5,287
$51.60
$272.83K
Shoemaker Daniel D
16 Nov 2020
Chief Scientific Officer
Sell
4,932
$50.37
$248.41K
Showing 250 of 387 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 298
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 155
Sales at will 197
Transactions with no price 0
Shares from compensation/vesting 38,862,198
Sales filed before the plan box existed 178
History held since 28 Nov 2016